Spacer S

InterSpace® Shoulder

THE ONLY PRE-FORMED SPACER SYSTEM WITH GENTAMICIN TO MAINTAIN JOINT STABILITY DURING TREATMENT OF INFECTED SHOULDER ARTHROPLASTY

The Spacer S temporarily replaces a Total Shoulder Arthroplasty (TSA) that has
been explanted due to infection. Spacer S is a pre-formed, partial load-bearing
device consisting of gentamicin-impregnated PMMA bone cement.

 

InterSpace Shoulder

Advantages

  • High Release formulation affords an
    increased surface area, which allows for
    greater antimicrobial activity than other
    treatment options1
  • Maintains joint space and allows limited
    mobility with partial weight bearing*
  • Improves quality of life between
    procedures2,3,4
  • Provides predictable, consistent local
    antibiotic release5
  • Facilitates implant placement during second-stage revision with greater ease for the
    surgeon2,3,6
  • Reduces hospitalization and allows for a
    seamless transition to rehabilitation and
    physical therapy6,7
  • Offers functional success rates equivalent to
    non-infected revisions.8

 

For the Second Stage:

Equinoxe® Shoulder System

The Equinoxe® Shoulder System is a primary stem that allows independent adjustability of all four anatomic paramaters in situ. The Equinoxe reverse shoulder is an optimized design that allows for maximized range of motion, improved stability and bone conservation. Its components build off the existing Equinoxe primary humeral stems, which enables surgeons to convert a well-fixed stem to a reverse without stem removal.

 

* Partial weight bearing must be assessed on an individual basis with relation to the anatomic condition of the local bone, bone quality and clinical conditions of the patient during rehabilitation stages. Care must be taken to minimize the risk of damaging bone tissue and the implant through excessive weight bearing or forced mobilization.

 

References

1. Soffiatti R. The preformed spacers: from the idea to the realization of an industrial device. In: Meani E, et al [ed].Infection and local treatment in Orthopedic surgery. Berlin: Springer-Verlag; 2007. 201-4.

2. Burnett S, Kelly M, Hanssen A, Barrack R. Technique and timing of two-stage exchange for infection in TKA. Clin Orthop Relat Res. 2007 Nov;464:164-78.

3. Castelli C, et al. Key points in two-stage revision for infected knee arthroplasty: bone loss, quality of life between stages and surgical approach at second stage. In: Meani E, et al [ed]. Infection and local treatment in orthopedic surgery. Berlin: Springer-Verlag; 2007. 294-301.

4. Su Y, Lee O, Chen W, Chen T. A facile technique to make articulating spacers for infected total knee arthroplasty. J Chin Med Assoc. 2009 Mar;72(3):138-45.

5. Bertazzoni Minelli E, Benini A, Magnan B, Bartolozzi P. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother. 2004 Feb;53(2):329-34. Epub 2003 Dec 19.

6. Diefenbeck M, Mückley T, Hofmann GO. Prophylaxis and treatment of implant-related infections by local application of antibiotics. Injury. 2006 May;37 Suppl 2:S95-104. Review.

7. Magnan B, et al. Two-stage revision of infected total hip replacement using a preformed, antibiotic-loaded acrylic cement spacer. In: Meani E, et al [ed]. Infection and local treatment in orthopedic surgery. Berlin: Springer-Verlag; 2007. 205-13.

8. Romano CL, Romano D, Logoluso N, Meani E. Aseptic versus septic total hip arthroplasty revision: comparing the results. Poster presented at the 76th Annual American Academy of Orthopaedic Surgeons Meeting; 2009 Feb 25-28; Las Vegas, NV.

Spacer S

 



Spacer S and Cemex® are produced by Tecres® S.p.A., Italy, and
distributed in Canada exclusively by Exactech, Inc.

 
Filed under: